Guildford-based Futura Medical, a healthcare company based at the Surrey Research Park, has announced that it has signed an exclusive licensing agreement with Ansell Limited, a global leader in protection solutions, for the marketing and distribution of its condom products, in China.
Ansell is a leading condom distributor in China including the country’s second largest condom brand, Jissbon. China has a population of 1.3 billion.
The financial details of the agreement with Ansell are not being disclosed although Futura will receive milestone payments and royalties on product sales along with certain minimum performance guarantees.
Ansell and Futura will work together to achieve regulatory approval in China for the CSD500 condom. The agreement builds on Futura’s existing relationship with Ansell, which already holds worldwide marketing rights to Futura’s novel spray for enhanced sexual control.
Peter Carroll, Ansell’s president and general manager – Sexual Wellness Global Business Unit, said: “We are very pleased to be strengthening our relationship with Futura by licensing rights to CSD500 in China, a region in which we have a major presence. CSD500 is a highly novel condom which we believe could have significant market potential in China.”
James Barder, Futura’s chief executive, commented: “We are delighted to sign this exclusive agreement with Ansell for the marketing and distribution of CSD500 in China, where Ansell has a strong market position through its Jissbon brand. China is potentially the world’s biggest market for condoms and we therefore look forward to working with Ansell to progress the product to launch.”
This website is published by The Guildford Dragon NEWS
Contact: Martin Giles mgilesdragon@gmail.com
Log in- Posts - Add New - Powered by WordPress - Designed by Gabfire Themes
Recent Comments